|
|
||||||||
Ann Thorac Surg 1996;62:1364-1372
© 1996 The Society of Thoracic Surgeons
Department of Cardiothoracic Surgery Research Laboratory, Bowman Gray School of Medicine, Winston-Salem, North Carolina
Accepted for publication May 29, 1996.
Background. Adenosine has been shown to reduce infarct size predominantly during reperfusion by adenosine A2receptor-mediated processes. This cardioprotection may involve inhibition of events in the vascular compartment, such as adherence-independent and adherence-dependent actions of neutrophils. This study tested the hypothesis that adenosine exerts its cardioprotection during reperfusion by targeting effectors in the vascular compartment.
Methods. Polyadenylic acid (molecular weight, 230,000 daltons) was used as an intravascularly confined adenosine mimetic. In anesthetized New Zealand white rabbits, the left coronary artery was occluded for 30 minutes and reperfused for 120 minutes.
Results. Polyadenylic acid (1 mg/kg bolus, 0.5 mg kg-1 h-1) given 5 minutes before reperfusion significantly (p < 0.05) reduced infarct size compared with vehicle (23% ± 2% versus 37% ± 2% area at risk). The A1-antagonist KW-3902 had no effect on this polyadenylic acid-induced protection (17% ± 3%), whereas the A1-A2 antagonist sulfophenytheophylline blocked this infarct size reduction (41% ± 2%). In vitro adherence of platelet-activating factor-activated neutrophils to thoracic aortic endothelium was significantly diminished by polyadenylic acid (185 ± 12 neutrophils/mm2 versus 36 ± 4 neutrophils/mm2 endothelial surface). Sulfophenytheophylline inhibited this effect (280 ± 6 neutrophils/mm2), whereas KW-3902 did not (31 ± 7 neutrophils/mm2).
Conclusions. An intravascular adenosine mimetic agent exerts cardioprotection during reperfusion by targeting receptor-mediated mechanisms in the intravascular compartment, possibly involving inhibition of neutrophil-related processes.
This article has been cited by other articles:
![]() |
A. Granfeldt, D. J. Lefer, and J. Vinten-Johansen Protective ischaemia in patients: preconditioning and postconditioning Cardiovasc Res, July 15, 2009; 83(2): 234 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Funakoshi, T. O. Chan, J. C. Good, J. R. Libonati, J. Piuhola, X. Chen, S. M. MacDonnell, L. L. Lee, D. E. Herrmann, J. Zhang, et al. Regulated Overexpression of the A1-Adenosine Receptor in Mice Results in Adverse but Reversible Changes in Cardiac Morphology and Function Circulation, November 21, 2006; 114(21): 2240 - 2250. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Willems, K. J. Ashton, and J. P. Headrick Adenosine-mediated cardioprotection in the aging myocardium Cardiovasc Res, May 1, 2005; 66(2): 245 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Yang, J. B. Proctor, L. Cui, T. Krieg, J. M. Downey, and M. V. Cohen Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1103 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Auchampach, X. Jin, J. Moore, T. C. Wan, L. M. Kreckler, Z.-D. Ge, J. Narayanan, E. Whalley, W. Kiesman, B. Ticho, et al. Comparison of Three Different A1 Adenosine Receptor Antagonists on Infarct Size and Multiple Cycle Ischemic Preconditioning in Anesthetized Dogs J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 846 - 856. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Headrick, B. Hack, and K. J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Muraki, C. D. Morris, J. M. Budde, D. A. Velez, Z.-Q. Zhao, R. A. Guyton, and J. Vinten-Johansen Experimental off-pump coronary artery revascularization with adenosine-enhanced reperfusion J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 570 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Merkus, D. W. Stepp, D. W. Jones, Y. Nishikawa, and W. M. Chilian Adenosine preconditions against endothelin-induced constriction of coronary arterioles Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2593 - H2597. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-L. Ma, F. Gao, B. L. Lopez, T. A. Christopher, and J. Vinten-Johansen Peroxynitrite, a Two-Edged Sword in Post-Ischemic Myocardial Injury---Dichotomy of Action in Crystalloid- Versus Blood-Perfused Hearts J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 912 - 920. [Abstract] [Full Text] |
||||
![]() |
M. B. Forman, J. V. Vitola, C. E. Velasco, J. J. Murray, R. K. Dubey, and E. K. Jackson Sustained Reduction in Myocardial Reperfusion Injury with an Adenosine Receptor Antagonist: Possible Role of the Neutrophil Chemoattractant Response J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 929 - 938. [Abstract] [Full Text] |
||||
![]() |
K. W. Mahaffey, J. A. Puma, N. A. Barbagelata, M. F. DiCarli, M. A. Leesar, K. F. Browne, P. R. Eisenberg, R. Bolli, A. C. Casas, V. Molina-Viamonte, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1711 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. H. Thourani, R. S. Ronson, D. G.L. Van Wylen, S. T. Shearer, S. L. Katzmark, Z.-Q. Zhao, D. C. Han, R. A. Guyton, and J. Vinten-Johansen Adenosine-Supplemented Blood Cardioplegia Attenuates Postischemic Dysfunction After Severe Regional Ischemia Circulation, November 9, 1999; 100 (2009): II-376 - II-383. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vinten-Johansen, V. H. Thourani, R. S. Ronson, J. E. Jordan, Z.-Q. Zhao, M. Nakamura, D. Velez, and R. A. Guyton Broad-spectrum cardioprotection with adenosine Ann. Thorac. Surg., November 1, 1999; 68(5): 1942 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-L. Liu, T. A. Christopher, B. L. Lopez, F. Gao, Y. Guo, E. Gao, K. Knuettel, M. Feelisch, and X. L. Ma SP/W-5186, A Cysteine-Containing Nitric Oxide Donor, Attenuates Postischemic Myocardial Injury J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 527 - 537. [Abstract] [Full Text] |
||||
![]() |
D. L Zarro, D. A Palanzo, and F. S Sadr Myocardial preconditioning using adenosine: review and clinical experience Perfusion, March 1, 1998; 13(2): 145 - 150. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |